Genzyme Corporation - Strategic SWOT Analysis Review

Date: August 2, 2016
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GC63D4CCD04EN
Leaflet:

Download PDF Leaflet

Genzyme Corporation - Strategic SWOT Analysis Review
Genzyme Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

    Highlights

    Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. The company’s products and services focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. Genzyme also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. The company operates through two business units namely, Rare Diseases business unit and Multiple Sclerosis business unit. Genzyme has presence across several geographies like Asia-Pacific, Europe and the Americas. The company is a subsidiary of Sanofi. Genzyme is headquartered in Massachusetts, the US.

    Genzyme Corporation Key Recent Developments

    Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.
  • SECTION 1 - ABOUT THE COMPANY

    Genzyme Corporation - Key Facts
    Genzyme Corporation - Key Employees
    Genzyme Corporation - Key Employee Biographies
    Genzyme Corporation - Major Products and Services
    Genzyme Corporation - Pharmaceutical Pipeline Products Data
    Genzyme Corporation, Pipeline Products by Therapy Area
    Genzyme Corporation, Pipeline Products by Development Phase
    Genzyme Corporation - History
    Genzyme Corporation - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Genzyme Corporation - Key Manufacturing Facilities
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Genzyme Corporation - Business Description
    Genzyme Corporation - Corporate Strategy
    Genzyme Corporation - SWOT Analysis
    SWOT Analysis - Overview
    Genzyme Corporation - Strengths
    Strength - Global Reach
    Strength - Synergy through Sanofi
    Strength - Research and Development Activities
    Genzyme Corporation - Weaknesses
    Weakness - Patent Litigations
    Genzyme Corporation - Opportunities
    Opportunity - New Market Approvals and Launches
    Opportunity - Promising Product Pipeline
    Opportunity - Changing Demographics
    Opportunity - Strategic Partnerships
    Genzyme Corporation - Threats
    Threat - Highly Competitive Industry
    Threat - Lengthy Drug Approval Process
    Threat - Emergence of Biogenerics / Biosimilars
    Genzyme Corporation - Key Competitors

    SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Genzyme Corporation, Recent Deals Summary

    SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

    Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE

    SECTION 5 – APPENDIX

    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Genzyme Corporation, Key Facts
    Genzyme Corporation, Key Employees
    Genzyme Corporation, Key Employee Biographies
    Genzyme Corporation, Major Products and Services
    Genzyme Corporation, Number of Pipeline Products by Therapy Area
    Genzyme Corporation, Number of Pipeline Products by Development Stage
    Genzyme Corporation, Pipeline Products By Therapy Area and Development Phase
    Genzyme Corporation, History
    Genzyme Corporation, Other Locations
    Genzyme Corporation, Subsidiaries
    Genzyme Corporation, Key Manufacturing Facilities
    Genzyme Corporation, Joint Venture
    Genzyme Corporation, Key Competitors
    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Genzyme Corporation, Recent Deals Summary

    LIST OF FIGURES

    Genzyme Corporation, Pipeline Products by Therapy Area
    Genzyme Corporation, Pipeline Products by Development Phase
    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Genzyme Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

    COMPANIES MENTIONED

    Recordati Rare Diseases Inc.
    Bellus Health Inc.
    Keryx Biopharmaceuticals, Inc.
    Bionature E.A. Ltd.
    Forward Pharma A/S
    Receptos, Inc.
    BioClonetics Immunotherapeutics, Inc.
    Cellphire, Inc.
    Genentech, Inc.
    GlaxoSmithKline plc
    Biogen Idec Inc.
    Shire Plc
    Amgen Inc.
    Novartis Vaccines and Diagnostics, Inc.
    Skip to top


    Ask Your Question

    Genzyme Corporation - Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: